Protalix BioTherapeutics, Inc.
Balance Sheet
| Line Item | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $51.2M | $63.3M | $76.4M | $54.8M | $86.4M | $52.0M | $27.0M | $35.9M |
| Accounts Receivable | $1.7M | $693.0K | — | $1.9M | $2.1M | $1.4M | $1.4M | $7.0M |
| Inventory | $7.8M | $5.2M | $5.8M | $3.5M | $8.0M | $4.0M | $279.0K | $1.2M |
| Total Current Assets | $62.7M | $71.9M | $85.9M | $65.5M | $97.9M | $61.2M | $32.5M | $46.3M |
| Property, Plant & Equipment | $7.7M | $8.7M | $9.7M | $11.3M | $13.7M | $16.3M | $18.3M | $17.5M |
| Goodwill | — | — | — | — | — | — | — | — |
| Intangible Assets (Excl. Goodwill) | — | — | — | — | — | — | — | — |
| Total Assets | $72.2M | $82.2M | $97.3M | $78.4M | $113.3M | $78.7M | $51.8M | $64.7M |
| Liabilities | ||||||||
| Accounts Payable | $9.3M | $7.5M | $5.5M | $6.8M | $5.3M | $5.3M | $5.0M | $6.3M |
| Total Current Liabilities | $22.8M | $66.2M | $11.2M | $64.4M | $26.7M | $25.8M | $18.7M | $18.9M |
| Long-Term Debt | — | — | — | $912.0K | $2.4M | $5.4M | $6.6M | — |
| Total Liabilities | $101.7M | $92.2M | $86.4M | $134.0M | $140.3M | $82.1M | $77.9M | $76.1M |
| Stockholders' Equity | ||||||||
| Retained Earnings | $-296.1M | $-212.7M | $-183.3M | $-241.3M | $-211.4M | $-183.6M | $-172.0M | $-135.4M |
| Total Stockholders' Equity | $-29.5M | $-10.0M | $10.9M | $-55.6M | $-26.9M | $-3.4M | $-26.1M | $-11.3M |